Copyright
©The Author(s) 2023.
World J Clin Cases. Jan 26, 2023; 11(3): 598-609
Published online Jan 26, 2023. doi: 10.12998/wjcc.v11.i3.598
Published online Jan 26, 2023. doi: 10.12998/wjcc.v11.i3.598
Table 1 General data of patients in the two groups, n (%)
| CDT group (n = 21) | AngioJet group (n = 44) | χ2/t | P values | |
| Age (yr old) | 55.24 ± 11.92 | 56.84 ± 14.19 | -0.447 | 0.656 |
| Male | 13 (61.90) | 21 (47.73) | 1.145 | 0.285 |
| Affected limbs (left) | 10 (47.62) | 20 (45.54) | 0.027 | 0.87 |
| Duration of symptoms | 11.23 ± 2.17 | 11.59 ± 2.08 | -0.63 | 0.531 |
| Risk factors (fracture types) | ||||
| Below the knee | 6 (28.57) | 8 (18.18) | 0.913 | 0.657 |
| Knee | 6 (28.57) | 14 (31.82) | ||
| Above the knee | 9 (42.86) | 22 (50.0) | ||
| Scope of thrombosis | ||||
| Femoral/popliteal/calf | 5 (23.81) | 6 (13.64) | 0.448 | 0.503 |
| Popliteal/calf | 16 (76.19) | 38 (86.36) | ||
| Filter types | ||||
| Denali | 22 (100.0) | 41 (93.18) | – | 0.545 |
Table 2 Intervention related data between these two groups of patients, n (%)
| CDT group (n = 21) | AngioJet group (n = 44) | χ2/t | P values | |
| Scope of thrombosis | ||||
| intra-filter thrombosis | 18 (85.71) | 38 (86.36) | 0 | 1 |
| intra-filter and IVC thrombosis | 3 (14.29) | 6 (13.64) | ||
| Pulmonary embolism | 4 (19.05) | 8 (18.18) | 0 | 1 |
| Left lung | 2 (9.52) | 3 (6.82) | – | 0.655 |
| Embolism of lobar artery | 1 (4.76) | 2 (0.45) | – | 1 |
| Embolism of segmental artery | 3 (14.29) | 6 (13.64) | 0 | 1 |
| Median urokinase dosage (million U, range) | 1.50 (1.17, 1.83) | 0.08 (0.02, 0.25) | -6.495 | 0 |
| Large-lumen catheter aspiration thrombus | 11 (52.38) | 33 (75.0) | 3.326 | 0.068 |
| D-Dimer (before intervention) | 12.10 (2.29, 30.93)a | 8.87 (2.01, 18.88)b | -4.472 | 0 |
| D-Dimer (after intervention) | 8.37 (2.67, 15.98)a | 7.14 (0.43, 22.05)b | -3.407 | 0.001 |
Table 3 Therapeutic effect and complications of patients in the two groups, n (%)
| CDT group (n = 21) | AngioJet group (n = 44) | χ2/t | P values | |
| Thrombus clearance grade | ||||
| Grade I (< 50%) | 2 (9.52) | 4 (9.09) | 0.281 | 0.922 |
| Grade II (50%-99%) | 11 (52.38) | 26 (59.09) | ||
| Grade III (100%) | 8 (38.10) | 14 (31.82) | ||
| Complications | ||||
| Haemoglobinuria | 0 | 7 (15.91) | – | 0.086 |
| Any bleed | 4 (19.05) | 0 | – | 0.009 |
| Bacteraemia | 1 (4.76) | 0 | – | 0.323 |
| PE after treatment | 2 (9.52) | 4 (9.09) | – | 1 |
| Left lung | 2 (9.52) | 0 | – | 0.101 |
| Embolism of segmental artery | 2 (9.52) | 4 (9.09) | – | 1 |
| Difference of circumference between affected and unaffected thigh (cm) | ||||
| Before treatment | 4.51 ± 0.65c | 4.76 ± 0.77d | -1.267 | 0.21 |
| After treatment | 1.44 ± 0.36d | 1.58 ± 0.51d | -1.089 | 0.28 |
| Length of stay (d) | 11.67 ± 5.34 | 10.64 ± 3.52 | 2.215 | 0.03 |
| Filter removal | ||||
| the first phase | 10 (47.62) | 15 (34.09) | 1.099 | 0.294 |
| the cumulative removal | 17 (80.95) | 42 (95.45) | – | 0.08 |
| IVCF retention time (d) | 16 (13, 139) | 59 (12, 231) | -0.991 | 0.322 |
| D-dimer after 1 mo (mg/L) | 0.24 (0.09, 2.15) | 0.26 (0.09, 2.62) | -4.346 | 0 |
- Citation: Li JY, Liu JL, Tian X, Jia W, Jiang P, Cheng ZY, Zhang YX, Liu X, Zhou M. Clinical outcomes of AngioJet pharmacomechanical thrombectomy versus catheter-directed thrombolysis for the treatment of filter-related caval thrombosis. World J Clin Cases 2023; 11(3): 598-609
- URL: https://www.wjgnet.com/2307-8960/full/v11/i3/598.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i3.598